Your browser doesn't support javascript.
loading
Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in AL amyloidosis.
Palladini, Giovanni; Paiva, Bruno; Wechalekar, Ashutosh; Massa, Margherita; Milani, Paolo; Lasa, Marta; Ravichandran, Sriram; Krsnik, Isabel; Basset, Marco; Burgos, Leire; Nuvolone, Mario; Lecumberri, Ramón; Foli, Andrea; Puig, Noemi; Sesta, Melania Antonietta; Bozzola, Margherita; Cascino, Pasquale; Nevone, Alice; Ripepi, Jessica; Berti, Pierpaolo; Casarini, Simona; Annibali, Ombretta; Orfao, Alberto; San-Miguel, Jesus; Merlini, Giampaolo.
Afiliação
  • Palladini G; Amyloidosis Research and Treatment Center, "Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo", Pavia, Italy. giovanni.palladini@unipv.it.
  • Paiva B; Biochemistry, Biotechnology and Advanced Diagnostics Laboratory, "Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo", Pavia, Italy. giovanni.palladini@unipv.it.
  • Wechalekar A; Department of Molecular Medicine, University of Pavia, Pavia, Italy. giovanni.palladini@unipv.it.
  • Massa M; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), IDISNA, CIBERONC CB16/12/00369 Pamplona, Pamplona, Spain.
  • Milani P; National Amyloidosis Centre, University College London (Royal Free Campus), London, UK.
  • Lasa M; Department of Haematology, University College London Hospitals, London, UK.
  • Ravichandran S; Biochemistry, Biotechnology and Advanced Diagnostics Laboratory, "Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo", Pavia, Italy.
  • Krsnik I; Amyloidosis Research and Treatment Center, "Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo", Pavia, Italy.
  • Basset M; Biochemistry, Biotechnology and Advanced Diagnostics Laboratory, "Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo", Pavia, Italy.
  • Burgos L; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), IDISNA, CIBERONC CB16/12/00369 Pamplona, Pamplona, Spain.
  • Nuvolone M; National Amyloidosis Centre, University College London (Royal Free Campus), London, UK.
  • Lecumberri R; Hospital Universitario Puerta del Hierro, Madrid, Spain.
  • Foli A; Amyloidosis Research and Treatment Center, "Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo", Pavia, Italy.
  • Puig N; Biochemistry, Biotechnology and Advanced Diagnostics Laboratory, "Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo", Pavia, Italy.
  • Sesta MA; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Bozzola M; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), IDISNA, CIBERONC CB16/12/00369 Pamplona, Pamplona, Spain.
  • Cascino P; Amyloidosis Research and Treatment Center, "Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo", Pavia, Italy.
  • Nevone A; Biochemistry, Biotechnology and Advanced Diagnostics Laboratory, "Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo", Pavia, Italy.
  • Ripepi J; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Berti P; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), IDISNA, CIBERONC CB16/12/00369 Pamplona, Pamplona, Spain.
  • Casarini S; Amyloidosis Research and Treatment Center, "Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo", Pavia, Italy.
  • Annibali O; Biochemistry, Biotechnology and Advanced Diagnostics Laboratory, "Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo", Pavia, Italy.
  • Orfao A; Servicio General de Citometría, Universidad de Salamanca, IBSAL, and IBMCC CSIC-USAL, CIBERONC, Salamanca, Spain.
  • San-Miguel J; Amyloidosis Research and Treatment Center, "Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo", Pavia, Italy.
  • Merlini G; Biochemistry, Biotechnology and Advanced Diagnostics Laboratory, "Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo", Pavia, Italy.
Blood Cancer J ; 11(2): 34, 2021 02 16.
Article em En | MEDLINE | ID: mdl-33594045
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasia Residual / Citometria de Fluxo / Amiloidose de Cadeia Leve de Imunoglobulina Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasia Residual / Citometria de Fluxo / Amiloidose de Cadeia Leve de Imunoglobulina Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article